US Stem Cell Inc (USRM)

[Gsdubb]

The law:
http://network.nature.com/groups/bioentrepreneur/forum/topics/7082

Mesoblast mentions it on their website for investors so they know
http://www.mesoblast.com/science/mesenchymal-precursor-cells/intellectual-property


Quote from this link “The approach established for generic medicines
is not suitable for development, evaluation and
licensing of similar biotherapeutic products
(SBPs) since biotherapeutics consist of relatively
large and complex proteins that are difficult
to characterize”. (8)

http://www.amgen.com/pdfs/misc/Biologics_and_Biosimilars_Overview.pdf


They'd have to match the Bioheart process exactly and even then there is exclusivity!

BAM!!